UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment

Yin Li,Manling Jiang,Ling Aye,Li Luo,Yong Zhang,Fengkai Xu,Yongqi Wei,Dan Peng,Xiang He,Jie Gu,Xiaofang Yu,Guoping Li,Di Ge,Chunlai Lu
DOI: https://doi.org/10.1038/s41467-024-45340-w
IF: 16.6
2024-02-09
Nature Communications
Abstract:The complexity of the tumor microenvironment (TME) is a crucial factor in lung adenocarcinoma (LUAD) progression. To gain deeper insights into molecular mechanisms of LUAD, we perform an integrative single-cell RNA sequencing (scRNA-seq) data analysis of 377,574 cells from 117 LUAD patient samples. By linking scRNA-seq data with bulk gene expression data, we identify a cluster of prognostic-related UPP1 high tumor cells. These cells, primarily situated at the invasive front of tumors, display a stronger association with the immunosuppressive components in the TME. Our cytokine array analysis reveals that the upregulation of UPP1 in tumor cells leads to the increased release of various immunosuppressive cytokines, with TGF-β1 being particularly prominent. Furthermore, this UPP1 upregulation also elevates the expression of PD-L1 through the PI3K/AKT/mTOR pathway, which contributes to the suppression of CD8 + T cells. Cytometry by time-of-flight (CyTOF) analysis provides additional evidence of the role of UPP1 in shaping the immunosuppressive nature of the TME. Using patient-derived organoids (PDOs), we discover that UPP1 high tumors exhibit relatively increased sensitivity to Bosutinib and Dasatinib. Collectively, our study highlights the immunosuppressive role of UPP1 in LUAD, and these findings may provide insights into the molecular features of LUAD and facilitate the development of personalized treatment strategies.
multidisciplinary sciences
What problem does this paper attempt to address?
The paper aims to explore the role of uridine phosphorylase 1 (UPP1) in the progression of lung adenocarcinoma (LUAD), particularly how it promotes tumor development by inducing an immunosuppressive microenvironment. Specifically, researchers analyzed single-cell RNA sequencing data from 117 LUAD patients and identified a group of tumor cells with high UPP1 expression associated with prognosis. These cells are primarily located at the tumor invasion front and are closely related to immunosuppressive components. Further studies indicate that upregulation of UPP1 in tumor cells promotes the release of various immunosuppressive cytokines, especially transforming growth factor β1 (TGF-β1), and upregulates PD-L1 expression through the PI3K/AKT/mTOR pathway, thereby inhibiting the function of CD8+ T cells. Additionally, UPP1 is associated with the enrichment of immunosuppressive cell populations such as regulatory T cells (Tregs), cancer-associated fibroblasts (CAFs), exhausted CD8+ T cells, and M2-like macrophages. These findings contribute to a deeper understanding of the molecular characteristics of LUAD and may provide a basis for the development of personalized therapeutic strategies.